Lenalidomide Capsules 10 Mg – Generic Revlimid

Lenalidomide Capsules 10 Mg – Generic Revlimid

Lenalidomide Capsules 10 Mg – Generic Revlimid is an immunomodulatory and anticancer medication used in the treatment of multiple myeloma, myelodysplastic syndromes (MDS), and certain types of lymphoma. It works by enhancing the immune system, inhibiting cancer cell growth, and preventing the formation of new blood vessels that support tumor development. This medication is widely used as part of combination therapy in oncology. In treatment planning, higher strengths such as Lenalidomide Capsules 15 Mg – Generic Revlimid and Lenalidomide Capsules 25 Mg – Generic Revlimid are commonly prescribed depending on the patient’s condition, response, and tolerance.

Mechanism of Action

Immunomodulatory Effects

Lenalidomide Capsules 10 Mg enhances immune system activity by stimulating T-cells and natural killer (NK) cells, which help target and destroy cancer cells.

Anti-Angiogenic Action

It also inhibits the formation of new blood vessels (angiogenesis) that tumors need for growth and survival.

Direct Antitumor Activity

The drug directly interferes with cancer cell proliferation, leading to reduced tumor progression. For detailed clinical insights, refer to National Cancer Institute (NCI) and for safety information, consult Mayo Clinic – Lenalidomide Drug Information.

Medical Uses

Lenalidomide Capsules 10 Mg – Generic Revlimid is used in:

• Multiple myeloma
• Myelodysplastic syndromes (MDS)
• Mantle cell lymphoma

It is often used in combination with other medications such as corticosteroids or chemotherapy agents to improve treatment outcomes.

Dosage and Administration

Lenalidomide Capsules 10 Mg is taken orally once daily, usually in cycles as prescribed by an oncologist. The dosage depends on the specific condition and patient tolerance. Treatment plans may include adjustments to Lenalidomide Capsules 15 Mg – Generic Revlimid or escalation to Lenalidomide Capsules 25 Mg – Generic Revlimid based on therapeutic response and safety monitoring.

Clinical Effectiveness

Clinical studies have shown that Lenalidomide significantly improves progression-free survival and overall response rates in patients with multiple myeloma and related conditions. It is considered a key component in modern hematologic cancer therapy.

Safety and Side Effects

Common Side Effects

• Fatigue
• Diarrhea or constipation
• Rash
• Low blood cell counts (anemia, neutropenia)

Serious Risks

• Blood clots (deep vein thrombosis)
• Severe neutropenia and infection risk
• Birth defects (teratogenic risk)

Regular blood monitoring is essential during treatment. For more details, refer to Mayo Clinic – Lenalidomide Drug Information.

Contraindications and Precautions

Lenalidomide Capsules 10 Mg should not be used in:

• Pregnancy (high risk of severe birth defects)
• Patients with severe hypersensitivity to the drug

Strict pregnancy prevention programs must be followed during treatment.

Drug Interactions

Lenalidomide Capsules 10 Mg may interact with anticoagulants, other anticancer drugs, and medications affecting the immune system. Patients should inform their healthcare provider about all medications they are taking. For research-based information, refer to National Cancer Institute (NCI).

FAQs